Angiology

Three Posters on SEL24/MEN1703 including Pharmacodynamic Data from the Dose Escalation Part of DIAMOND-01 Trial to be published at American Society of Hematology (ASH) Annual Meeting

Retrieved on: 
Tuesday, December 1, 2020
Angiology, Angiogenesis

Together with Menarini, we are fully focused on delivering the most effective and safe treatment options to cancer patients worldwide."

Key Points: 
  • Together with Menarini, we are fully focused on delivering the most effective and safe treatment options to cancer patients worldwide."
  • DIAMOND-01 is the First-in-Human, Phase I/II dose escalation and cohort expansion trial of SEL24/MEN1703, in-licensed from Ryvu Therapeutics by Menarini, in AML.
  • Hence, targeting PIM kinases may represent an efficient approach to induce tumor cell death and to block angiogenesis in MM.
  • Ryvu Therapeutics is listed on the main market of the Warsaw Stock Exchange, and has been a component of sWIG80 index since March 2017.

Global Acute Ischemic Stroke Therapeutics Market 2020-2024 | $ 1.22 Billion Incremental Growth at 5% CAGR | Technavio

Retrieved on: 
Tuesday, December 1, 2020
Health, General Health, Angiology, Ischemia, Stroke, Coronavirus disease, Health, Medicine

The acute ischemic stroke therapeutics market is poised to grow by USD 1.22 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period.

Key Points: 
  • The acute ischemic stroke therapeutics market is poised to grow by USD 1.22 billion during 2020-2024, progressing at a CAGR of over 5% during the forecast period.
  • View the full release here: https://www.businesswire.com/news/home/20201130005604/en/
    Technavio has announced its latest market research report titled Global Acute Ischemic Stroke Therapeutics Market 2020-2024 (Graphic: Business Wire)
    Worried about the impact of COVID-19 on your Business?
  • The report on the acute ischemic stroke therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
  • The acute ischemic stroke therapeutics market analysis includes the type and geography landscape.

Venclose to Participate in 2020 Piper Sandler Healthcare Conference

Retrieved on: 
Monday, November 30, 2020
Angiology, Cardiovascular system, Circulatory system, Veins, Venous insufficiency, Vascular diseases, Vascular surgery, Chronic venous insufficiency, Varicose veins, Insufficiency

SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ -- Venclose Inc., a privately-held medical device corporation focused on innovative advancements for the minimally invasive treatment of chronic venous insufficiency, a major underlying cause of varicose veins, today announced that Jerry Gibson, Venclose Chairman and CEO, will participate in the 32nd Annual Piper Sandler Healthcare Conference taking place virtually November 30 - December 3, 2020.

Key Points: 
  • SAN JOSE, Calif., Nov. 30, 2020 /PRNewswire/ -- Venclose Inc., a privately-held medical device corporation focused on innovative advancements for the minimally invasive treatment of chronic venous insufficiency, a major underlying cause of varicose veins, today announced that Jerry Gibson, Venclose Chairman and CEO, will participate in the 32nd Annual Piper Sandler Healthcare Conference taking place virtually November 30 - December 3, 2020.
  • "Venclose is honored to be one of the 40 private companies selected to participate in this year's conference," commented Mr. Gibson.
  • "We are pleased to share the company's commercial progress, a direct reflection of the quality of products in the Venclose portfolio and the hard work of its valued employees.
  • The Venclose Corporate Overview presentation can be viewed in the Newsroom section of the Venclose website: https://venclose.com/news/ .

Idorsia announces positive results of the two Japanese registration studies with clazosentan

Retrieved on: 
Monday, November 23, 2020
Neurosurgery, Angiology, Vasospasm, ASAH

Idorsia Ltd (SIX: IDIA) today announced positive top-line results of the Japanese registration program investigating clazosentan in adult Japanese patients post-aSAH.

Key Points: 
  • Idorsia Ltd (SIX: IDIA) today announced positive top-line results of the Japanese registration program investigating clazosentan in adult Japanese patients post-aSAH.
  • Both studies demonstrated that clazosentan reduced the occurrence of cerebral vasospasm-related morbidity and all-cause mortality within 6 weeks post-aSAH with statistical significance (p
  • The studies confirmed the well documented safety profile of clazosentan which has now been administered to over 2000 patients around the globe.
  • In these registration studies in Japanese patients post-aSAH there were no unexpected safety findings.

Multiple Sclerosis: Is Therapeutic Angiogenesis a Treatment or Even a Possible Cure?

Retrieved on: 
Wednesday, November 18, 2020
Angiology, Medical specialties, Angiogenesis, Endothelium, Multiple sclerosis, Clinical medicine, Draft:Zhittya Genesis Medicine

The webinar will be broadcast on Monday, November 23, 2020, at 9:00 am Pacific (12 noon Eastern).

Key Points: 
  • The webinar will be broadcast on Monday, November 23, 2020, at 9:00 am Pacific (12 noon Eastern).
  • Zhittya believes this endothelial dysfunction could be the root cause of multiple Sclerosis.
  • Zhittya has prepared a regulatory application to conduct a human clinical trial with its therapeutic angiogenesis molecule, human FGF-1, in patients with MS.
  • We believe that disrupted blood flow in the brain and spine is the cause of multiple sclerosis.

Global Capillary and Venous Blood Sampling Devices Market (2020 to 2030) - Industry Analysis, Size, Share, Growth, Trends, and Forecast

Retrieved on: 
Friday, November 13, 2020
Cardiovascular system, Circulatory system, Angiology, Veins, Cardiovascular physiology, Capillary, Sampling, Compound annual growth rate

The report provides revenue of the global capillary and venous blood sampling devices market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year.

Key Points: 
  • The report provides revenue of the global capillary and venous blood sampling devices market for the period 2018-2030, considering 2019 as the base year and 2030 as the forecast year.
  • The report also provides the compound annual growth rate (CAGR %) of the global capillary and venous blood sampling devices market from 2020 to 2030.
  • Moreover, the report sheds light on the changing competitive dynamics in the global capillary and venous blood sampling devices market.
  • The report delves into the competitive landscape of the global capillary and venous blood sampling devices market.

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Business Update

Retrieved on: 
Wednesday, November 11, 2020
Angiology, Anatomy, Branches of biology, Forward-looking statement, Lung, Vascular smooth muscle, Blood vessel, Artery, Respiratory tract

Additionally, Beyond Air is using ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting.

Key Points: 
  • Additionally, Beyond Air is using ultra-high concentrations of NO with a proprietary delivery system to target certain solid tumors in the pre-clinical setting.
  • In the airways, NO targets the vascular smooth muscle cells that surround the small resistance arteries in the lungs.
  • Forward-looking statements include statements about our expectations, beliefs, or intentions regarding our product offerings, business, financial condition, results of operations, strategies or prospects.
  • Rather, forward-looking statements relate to anticipated or expected events, activities, trends or results as of the date they are made.

Compression Therapy Market to Clock CAGR of 6.1% from 2019 to 2027, Use of Therapy among Athletes to Promote Recovery from Injuries on Rise, Says TMR

Retrieved on: 
Tuesday, November 10, 2020
Medical specialties, Hematology, Angiology, Venous ulcer, Thrombosis, Deep vein thrombosis, Lymphedema, Venous thrombosis, Compression stockings

Rise in orthopedic surgeries and favorable reimbursement policies in vascular disease treatment has set the pace for the expansion in the compression therapy market.

Key Points: 
  • Rise in orthopedic surgeries and favorable reimbursement policies in vascular disease treatment has set the pace for the expansion in the compression therapy market.
  • The valuation of the compression therapy market stood at US$ 3.2 Bn in 2018 and is projected to clock CAGR of 6.1% from 2019 to 2027.
  • The increase in risk of vascular diseases, including venous ulcers, lymphedema, and deep vein thrombosis, has also fueled the prospects in the compression therapy market.
  • Further, constant research on compression therapies for sports injuries in the regional market has also cemented the potential of the regional market.

Capillary and Venous Blood Sampling Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, November 10, 2020
Medical devices, Health, Cardiovascular system, Circulatory system, Angiology, Veins, Capillary, Sampling, Vascular diseases

The report also provides the compound annual growth rate (CAGR %) of the global capillary and venous blood sampling devices market from 2020 to 2030.

Key Points: 
  • The report also provides the compound annual growth rate (CAGR %) of the global capillary and venous blood sampling devices market from 2020 to 2030.
  • Moreover, the report sheds light on the changing competitive dynamics in the global capillary and venous blood sampling devices market.
  • These serve as valuable tools for existing market players as well as for entities interested in participating in the global capillary and venous blood sampling devices market.
  • The report delves into the competitive landscape of the global capillary and venous blood sampling devices market.

Outlook on the Capillary and Venous Blood Sampling Devices Global Market to 2030 - Impact Analysis of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Monday, November 9, 2020
Health, Medical devices, Other Health, Angiology, Hematology, Sampling, Blood, Capillary, Science, Articles, Health

Global Capillary and Venous Blood Sampling Devices Market Value Share and Attractiveness Analysis, by Product

Key Points: 
  • Global Capillary and Venous Blood Sampling Devices Market Value Share and Attractiveness Analysis, by Product
    6.4.
  • Global Capillary and Venous Blood Sampling Devices Market Forecast, by Product
    6.5.
  • Global Capillary and Venous Blood Sampling Devices Market Analysis, by Product
    7.
  • Global Capillary and Venous Blood Sampling Devices Market Forecast, by Region
    View source version on businesswire.com: https://www.businesswire.com/news/home/20201109005860/en/